Undifferentiated Ovarian Carcinoma Completed Phase 1 Trials for Glutamic acid (DB00142)

IndicationStatusPhase
DBCOND0028876 (Undifferentiated Ovarian Carcinoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00060359Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerTreatment